shortagewatch

Home / Cancer and immune system / Nintedanib

ATC L01EX09 · Antineoplastic Agents

Nintedanib shortage

As of 31 Oct 2026, Nintedanib has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 7 products.

Countries2/5
Products7packs or presentations
Short since26 Aug 20262 months ago
Earliest return14 Nov 2026company estimate
No return date4products
Main reasonIncreased demand

Timeline

ItalySpain
2027NINTEDANIB SANDOZNINTEDANIB SANDOZNINTEDANIB SANDOZNINTEDANIB SANDOZNINTEDANIB DR. REDDY’SNINTEDANIB DR. REDDY’SNINTEDANIB DR. REDDY’SNINTEDANIB DR. REDDY’SNINTEDANIB DR.REDDYS 100 MG CAPSULAS BLANDASNINTEDANIB DR.REDDYS 100 MG CAPSULAS BLANDAS EFG, 60 cápsulasNINTEDANIB DR.REDDYS 150 MG CAPSULAS BLANDASNINTEDANIB DR.REDDYS 150 MG CAPSULAS BLANDAS EFG, 60 cápsulasNINTEDANIB EUGIA 150 MG CÁPSULAS BLANDAS EFGNINTEDANIB EUGIA 150 MG CÁPSULAS BLANDAS EFG, 60 cápsulastoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITNINTEDANIB SANDOZSANDOZ S.P.A.26 Aug 2026not givenIncreased demand
Elevata richiesta
ITNINTEDANIB SANDOZSANDOZ S.P.A.26 Aug 2026not givenIncreased demand
Elevata richiesta
ITNINTEDANIB DR. REDDY’SDR. REDDY'S S.R.L.17 Sep 2026not givenIncreased demand
Elevata richiesta (carenza relativa solo al canale ospedaliero)
ITNINTEDANIB DR. REDDY’SDR. REDDY'S S.R.L.17 Oct 2026not givenIncreased demand
Elevata richiesta (carenza relativa solo al canale ospedaliero)
ESNINTEDANIB DR.REDDYS 100 MG CAPSULAS BLANDAS EFG, 60 cápsulasReddy Pharma Iberia S.A.9 Sep 202615 Dec 2026Not stated
ESNINTEDANIB DR.REDDYS 150 MG CAPSULAS BLANDAS EFG, 60 cápsulasReddy Pharma Iberia S.A.10 Sep 202615 Dec 2026Not stated
ESNINTEDANIB EUGIA 150 MG CÁPSULAS BLANDAS EFG, 60 cápsulasEugia Pharma (Malta) Limited17 Sep 202614 Nov 2026Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply